The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Heart Closure Devices Market Between 2026 And 2030?
The heart closure devices market has experienced significant expansion in recent years. It is anticipated to grow from $3.08 billion in 2025 to $3.46 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.2%. The historical increase can be attributed to the rising prevalence of congenital heart defects, the expansion of catheterization laboratories, the increasing adoption of minimally invasive cardiac treatments, greater awareness of structural heart conditions, and the availability of advanced imaging guidance.
The heart closure devices market size is projected for significant expansion in the coming years. This market is anticipated to reach $5.42 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.9%. This projected growth is driven by several factors, including the increasing demand for catheter-based cardiac therapies, heightened investments in structural heart disease treatment, the expansion of specialized cardiac centers, a greater emphasis on minimizing surgical risks, and ongoing technological advancements in closure device design. Key trends anticipated during this period encompass the growing adoption of transcatheter heart closure procedures, a rising demand for minimally invasive cardiac devices, the expanding utilization of nitinol-based closure systems, the enlargement of structural heart intervention programs, and an elevated focus on procedural safety and efficacy.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20828&type=smp
Which Key Drivers Are Affecting The Heart Closure Devices Market Development?
The rising prevalence of cardiovascular diseases (CVDs) is projected to boost the expansion of the heart closure devices market moving forward. This surge in CVDs is attributed to factors like an aging population, unhealthy lifestyle choices, genetic predispositions, and the increasing occurrence of risk factors such as hypertension, diabetes, and obesity. Heart closure devices are instrumental in reducing complications from congenital heart defects by providing a minimally invasive means to seal abnormal openings in the heart, thereby enhancing blood flow and preventing subsequent health complications. As an illustration, in May 2024, the Singapore Heart Foundation (SHF), a non-profit organization based in Singapore, reported that cardiovascular disease caused a total of 26,885 deaths in 2023. Furthermore, ischemic heart disease alone accounted for 5,302 deaths, representing an increase from 5,290 deaths in 2022. Thus, the growing incidence of cardiovascular diseases (CVDs) is propelling the growth of the heart closure devices market.
How Is The Heart Closure Devices Market Broken Down By Segment Categories?
The heart closure devices market covered in this report is segmented –
1) By Product: Atrial Septal Defect (ASD) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Left Atrial Appendage (LAA) Closure Devices, Other Products
2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials
3) By Mode of Delivery: Transcatheter Delivery, Surgical Delivery
4) By End Use: Hospitals, Ambulatory Surgical Centers (ASCs), Cardiac Catheterization Laboratories, Other End Uses
Subsegments:
1) By Atrial Septal Defect (ASD) Closure Devices: Self-expanding Occluders, Balloon-expandable Occluders, Other ASD Closure Devices
2) By Ventricular Septal Defect (VSD) Closure Devices: Transcatheter VSD Closure Devices, Surgical VSD Closure Devices, Other VSD Closure Devices
3) By Patent Foramen Ovale (PFO) Closure Devices: Double-Disc Occluders, Single-Disc Occluders, Other PFO Closure Devices
4) By Left Atrial Appendage (LAA) Closure Devices: LAA Occluders, LAA Clip Systems, Other LAA Closure Devices
5) By Other Products: Septal Defect Closure Devices, Endovascular Closure Devices, Other Specialty Closure Devices
What Trends Are Transforming The Heart Closure Devices Market?
Companies operating within the heart closure devices market are increasingly concentrating on technological advancements, such as developing low-profile, ergonomic surgical LAA devices that incorporate continuous closing force mechanisms. This focus aims to elevate procedural accuracy, enhance visibility, and simplify use for medical professionals, consequently improving patient outcomes. Low-Profile Surgical LAA Devices enable secure and effective closure of the left atrial appendage, delivering optimal tissue compression, streamlined single-handed placement, and better access in minimally invasive procedures. For instance, in August 2024, AtriCure, Inc., a US-based cardiac surgical solutions company, initiated treatment for its first patient using its AtriClip FLEX-Mini device, which is currently the smallest-profile surgical LAA device available. Leveraging the established AtriClip platform, the device features a completely enclosed design with parallel beams to ensure continuous closing force, offers improved visibility, and includes an ergonomic handle for single-handed placement, thereby assisting physicians in providing precise, safe, and efficient LAA management for individuals suffering from atrial fibrillation.
Which Players Are Present In The Heart Closure Devices Market Space?
Major companies operating in the heart closure devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Lepu Medical Technology Ltd., Terumo Corporation, Edwards Lifesciences, Teleflex Incorporated, Merit Medical Systems Inc., Cordis Corporation, AtriCure Inc., Lifetech Scientific Corp., Sahajanand Medical Technologies, W. L. Gore And Associates Inc., Occlutech GmbH, NMT Medical Inc., Sorin Group Italia S.p.A., Vivasure Medical Limited, B Braun Interventional Systems, HeartStitch Inc., MicroPort Scientific Corporation
Get The Full Heart Closure Devices Market Report:
https://www.thebusinessresearchcompany.com/report/heart-closure-devices-global-market-report
Which Region Accounts For The Largest Portion Of The Heart Closure Devices Market?
North America was the largest region in the heart closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Heart Closure Devices Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=20828&type=smp
Browse Through More Reports Similar to the Global Heart Closure Devices Market 2026, By The Business Research Company
Heart Pump Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report
Heart Blocks Treatment Devices Market Report 2026
Congestive Heart Failure Treatment Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model